Novo Nordisk Share Holder Equity 1988-2025 | NVO
Novo Nordisk share holder equity from 1988 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Novo Nordisk share holder equity for the quarter ending June 30, 2025 was $25.563B, a 57.44% increase year-over-year.
- Novo Nordisk share holder equity for 2024 was $20.805B, a 34.47% increase from 2023.
- Novo Nordisk share holder equity for 2023 was $15.473B, a 30.88% increase from 2022.
- Novo Nordisk share holder equity for 2022 was $11.822B, a 5.03% increase from 2021.
Novo Nordisk Annual Share Holder Equity (Millions of US $) |
|
---|---|
2024 | $20,805 |
2023 | $15,473 |
2022 | $11,822 |
2021 | $11,256 |
2020 | $9,701 |
2019 | $8,633 |
2018 | $7,926 |
2017 | $7,567 |
2016 | $6,727 |
2015 | $6,989 |
2014 | $7,184 |
2013 | $7,582 |
2012 | $7,021 |
2011 | $6,999 |
2010 | $6,591 |
2009 | $6,693 |
2008 | $-89 |
2007 | $5,921 |
2006 | $5,060 |
2005 | $4,615 |
2004 | $4,426 |
2003 | $3,844 |
2002 | $3,222 |
2001 | $2,392 |
2000 | $1,971 |
1999 | $2,049 |
1998 | $26,958 |
1997 | $2,729 |
1996 | $2,751 |
1995 | $2,602 |
1994 |